Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 130 followers

Latest posts

Last updated 1 day ago

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 12, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson...

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic, Date of authorisation: 31/07/2020, Revision: 4, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic...

Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Hepatitis C, Chronic, Date of authorisation: 17/11/2014, Revision: 23, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Hepatitis C, Chronic...

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Erectile Dysfunction, Date of authorisation: 13/09/1998, Revision: 37, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Erectile Dysfunction, Date...

Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Hyperparathyroidism, Secondary, Date of authorisation: 11/11/2016, Revision: 9, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Hyperparathyroidism, Secondary, Date...

Human medicines European public assessment report (EPAR): Cystadane, betaine anhydrous, Homocystinuria, Date of authorisation: 14/02/2007, Revision: 14, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Cystadane, betaine anhydrous, Homocystinuria, Date...

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2016, Revision: 12, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Diabetes Mellitus, Type...